Floatz logo

Therapeutic Asset Ratings

186 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sildenafil
Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity
Tanta UniversityP3B (58)
Baclofen
Morbid Obesity
Tanta UniversityP2/3B (58)
Pentoxifylline
Breast Cancer
Tanta UniversityP2/3B (58)
Letrozole
Epilepsy
Tanta UniversityP3B (57)
Cyclophosphamide
Doxorubicin Induced Cardiotoxicity
Tanta UniversityP2B (57)
Dapagliflozin
Depressive Disorder
Tanta UniversityP2B (57)
Fenofibrate
Breast Cancer Stage 2 and 3
Tanta UniversityP2B (57)
Lipitor
Depressive Disorder
Tanta UniversityP2B (57)
MELATONIN
Breast Cancer Patients Diagnosed
Tanta UniversityP2B (57)
N-Acetyl-L-Cysteine
Drug Resistant Epilepsy
Tanta UniversityP2B (57)
Roflumilast
Non-Alcoholic Steatohepatitis (NASH)
Tanta UniversityP2B (57)
Allopurinol
Ascites
Tanta UniversityP2/3B (57)
Allopurinol
SBP - Spontaneous Bacterial Peritonitis
Tanta UniversityP2/3B (57)
Allopurinol
Varices
Tanta UniversityP2/3B (57)
Calcium folinate pentahydrate
Mucositis
Tanta UniversityP1/2B (57)
Lipitor
Ascites
Tanta UniversityP2/3B (57)
Lipitor
SBP - Spontaneous Bacterial Peritonitis
Tanta UniversityP2/3B (57)
Lipitor
Varices
Tanta UniversityP2/3B (57)
Namenda
Peripheral Nerve Disease
Tanta UniversityP2/3B (57)
Rosuvastatin
Peripheral Nerve Disease
Tanta UniversityP2/3B (57)
Silymarin
Peripheral Neuropathy
Tanta UniversityP2/3B (57)
Fenofibrate
Multiple Myeloma
Tanta UniversityP4CCC (55)
Allopurinol
Hepatic Encephalopathy
Tanta UniversityP2/3CCC (55)
Lipitor
Hepatic Encephalopathy
Tanta UniversityP2/3CCC (55)
Nicorandil
Diabetes Mellitus, Type 2
Tanta UniversityP2/3CCC (55)
Showing 76 to 100 of 186 assets
PreviousPage 4 of 8Next